We are thrilled to share that Ms. Jennifer Che, our President and Managing Director, has been recognized in IAM Strategy 300 Global Leaders 2026. This follows our recent announcement recognizing Ms. Che in the list of IAM Global Leaders 2026, which focuses on patent prosecution.

IAM Strategy 300 showcases the top strategy experts in the IP world. It is the “only resource of its kind, acknowledging leaders from across in-house, private practice and service provider roles”. A slot in the 300 is the “mark of a professional whose approach to intellectual property is regarded by peers as truly strategic in nature.”

IAM's comprehensive research process involved gathering nominations and insights from thousands of sources over a five month period, leading to in-depth interviews with selected candidates.

Jennifer's inclusion in this elite group is a testament to her ability to inspire and innovate, continually providing exceptional value to our clients and setting a benchmark in the industry.


Please join us in congratulating Jennifer on this well-deserved recognition. Her expertise and dedication to her work make her an invaluable asset to our team and our clients.

我們過去活動

Recommended Insights

Updates on Hong Kong Patents Examination Guidelines in 2024

2024年2月29日
The Intellectual Property Department of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China (HKIPD) has recently made several updates to the Hong Kong Patents Examination Guidelines, effective from 26 January, 2024. These changes mainly clarify and reflect the Registry’s current practices regarding patent examination for Standard Patent (R) […]

Amendments to the China Patent Examination Guidelines in 2022 - Part 1: New rules for designs in view of China signing onto the Hague Agreement

2022年12月2日
This year, China stepped further onto the international scene by signing on as a member of the Hague Agreement. The Hague Agreement is an international registration system allowing applicants to file a single international design application in a single language to obtain protection in over 100 designated member countries. The US has been a member […]

Everything you need to know about Patent Term Adjustment (PTA) in China

2024年5月7日
We previously discussed patent term compensation for patent office delay (‘Patent Term Adjustment’ or ‘PTA’) when such new system was introduced in the Fourth Amendment of the Chinese Patent Law (2020), as well as in the different versions of the Draft Examination Guidelines released in 2021 and 2022. In this article, we consolidate everything you need to […]

China Releases Draft Implementation Guidelines for the Drug Administration Law

2022年6月2日
The latest draft implementation guidelines for China’s Drug Administration Law (“Guidelines”) are out and open for comment. Previously, the new implementation measures for early dispute resolution mechanisms for drug patents (“Patent Linkage Measures”) came into effect on July 4, 2021. The Guidelines indicate that the final approval of generic chemical drug applications for marketing approval […]
Top crossarrow-right